Is Onion Oil Safe During Breastfeeding: What We Know and What We Do Not

Quick Answer: Topical onion oil applied to the scalp is generally considered low-risk during breastfeeding, because the scalp absorbs very little into the bloodstream when products are kept away from the nipple, areola and broken skin. However, no published randomised controlled trial has tested onion oil safety specifically in lactating women, and the 2025 International Journal of Dermatology review on alopecia treatments in breastfeeding does not classify onion oil as either confirmed-safe or contraindicated (Needle et al., International Journal of Dermatology, 2025). The closest clinical evidence is a 2002 Journal of Dermatology randomised trial in which crude onion juice produced significant hair regrowth in alopecia areata, 73.9% at 4 weeks and 86.9% at 6 weeks versus 13% for placebo, though that trial was not conducted in postpartum women (Sharquie and Al-Obaidi, Journal of Dermatology, 2002). The pragmatic guidance, drawn from FDA scalp-oil labelling precedent, is to use the smallest area for the shortest duration, never apply to the nipple or areola, patch test before first use, and avoid concurrent topical agents that are not breastfeeding-compatible (FDA Derma-Smoothe/FS Scalp Oil Label, 2024).

TL;DR

• No direct evidence: zero published RCTs test onion oil safety during breastfeeding, and the 2025 International Journal of Dermatology alopecia-in-lactation review does not classify it (Needle et al., 2025).

• What is known: onion is widely consumed as food, and well-formulated scalp oils show minimal systemic absorption when kept off the nipple and areola (FDA Derma-Smoothe/FS Scalp Oil Label, 2024).

• What is uncertain: no pharmacokinetic data exist on onion seed oil compounds, such as quercetin and sulphur compounds, crossing into breast milk after topical scalp use.

• Caution versus contraindicated: finasteride and other hormone-based hair treatments are contraindicated during breastfeeding; topical minoxidil is classed as low-risk but the 2025 review still advises cautious use, particularly around premature infants (Needle et al., 2025).

• The data-gap reality: a 2018 audit found 54% of the 1,408 drugs in the LactMed database had no breastfeeding safety data, and only 2% had sound evidence (ConcePTION project, Frontiers in Pharmacology, 2025).

• Practical protocol: patch test, apply to the scalp only, wash hands before handling the baby, and avoid stacking with concentrated essential oils or retinoids.

What Is Onion Oil?

Onion oil is a topical hair preparation built around onion (Allium cepa) extract or onion seed oil, blended with carrier oils and supporting botanicals. The bioactive interest lies in its sulphur compounds and the flavonoid quercetin, both studied for antioxidant and follicle-stimulating effects (Sharquie and Al-Obaidi, Journal of Dermatology, 2002). Onion oil has a long history in Indian and Ayurvedic hair care, which is part of why it is a familiar first choice for Indian mothers facing postpartum hair fall.

Postpartum hair fall itself has a clinical name: telogen effluvium. Telogen effluvium is a temporary, diffuse shedding of hair that usually begins 2 to 3 months after delivery, when follicles that stayed in the growth phase through pregnancy shift together into the resting phase. It typically resolves on its own within 6 to 12 months, and shedding can run longer in women who breastfeed (Johns Hopkins Medicine, 2025).

Mylo's Onion Hair Oil is formulated as a Pre and Post Pregnancy Hairfall Oil, fortified with onion seed oil, Amla, Bhringraj, Ylang Ylang, Methi (fenugreek), and Vitamins A and D3, in a 200 ml format. It sits within the Mylo Care Hair range and is positioned for the postpartum hair-fall window, alongside an onion shampoo, conditioner and serum (Mylo Family, 2026).

What Does the Clinical Evidence Show?

The strongest efficacy evidence for onion on hair comes from a 2002 randomised controlled trial in the Journal of Dermatology. It enrolled 38 patients with alopecia areata and randomised them to crude onion juice or tap water, applied twice daily. At 4 weeks, 73.9% of the onion group showed terminal hair regrowth; by 6 weeks this rose to 86.9%, against 13% in the control group (Sharquie and Al-Obaidi, Journal of Dermatology, 2002). This trial is the foundation cited across modern onion oil literature. Two limits matter: it studied alopecia areata, not postpartum shedding, and it was not conducted in breastfeeding women.

The breastfeeding-specific evidence is simply absent. The 2025 International Journal of Dermatology review by Needle and colleagues catalogues lactation safety for the most-used hair regrowth options, from ketoconazole shampoo to laser therapy to plant-based remedies. The point for onion oil is what the review does not say: onion oil is not classified at all. That leaves it where most cosmetic ingredients sit, assumed low-risk by topical convention, but without dedicated lactation pharmacokinetic studies (Needle et al., International Journal of Dermatology, 2025).

Why Is There No Direct Safety Data on Onion Oil in Breastfeeding?

The gap is not unique to onion oil. A 2018 audit carried forward by the ConcePTION project found that 54% of the 1,408 drugs in the LactMed database had no breastfeeding-related safety data, and only 2% had sound, methodologically robust evidence (ConcePTION project, Frontiers in Pharmacology, 2025). For a cosmetic botanical like onion oil, where no pharmaceutical sponsor is funding lactation pharmacokinetic trials, that absence of data is the norm, not the exception.

The practical implication is that most assessments of topical scalp products during breastfeeding rely on first-principles reasoning: how much the scalp absorbs, the chemical class of the active ingredient, and whether it carries a hormone-disrupting profile.

What Does FDA Scalp-Oil Labelling Tell Us About Absorption?

The FDA-approved label for Derma-Smoothe/FS Scalp Oil is the most useful precedent here. That product contains a corticosteroid, fluocinolone acetonide, and its label addresses breastfeeding directly (FDA Derma-Smoothe/FS Scalp Oil Label, 2024). Even for an active pharmaceutical ingredient, the FDA's guidance is simple: use the scalp oil on the smallest possible area, for the shortest possible duration while breastfeeding, and never on the nipple or areola.

That is the precedent framework for any topical scalp product during lactation, including a cosmetic onion oil. The scalp's skin barrier limits how much crosses into the bloodstream when the product stays within the application zone.

Which Hair Treatments Need Caution or Should Be Avoided While Breastfeeding?

Not every hair treatment carries the same risk during breastfeeding. The 2025 International Journal of Dermatology review sorts the common options into clear bands:

The table makes one correction worth stating plainly: minoxidil belongs in the caution band, not the avoid band. Earlier framing that called it simply not recommended overstates the evidence (Needle et al., International Journal of Dermatology, 2025). The genuine contraindications are finasteride and other hormone-based treatments, ruled out for their anti-androgenic and teratogenic risk. Onion does not share that hormonal profile, and has never been classified as an anti-androgen, which is the main reason it does not raise the same flags.

How Should You Use Onion Oil Safely While Breastfeeding?

If you are breastfeeding and want to use onion oil, the precautionary framework drawn from FDA labelling, the 2025 alopecia-in-lactation review, and standard postpartum dermatology practice is:

• Patch test first. Apply a small amount to the inner forearm, leave it for 24 hours, and watch for redness or itching.

• Apply to the scalp only. Avoid the hairline near the face if you carry your baby close, and never apply to the nipple, areola, or any skin your baby's mouth or skin contacts.

• Wash your hands thoroughly before handling your baby after application.

• Use the smallest effective amount and the lowest frequency that works. Most clinical onion juice protocols applied once or twice daily.

• Be cautious with concentrated essential oils. The real concern is undiluted essential oils applied directly to skin, some of which carry hormone-disrupting potential. A small amount of a botanical such as Ylang Ylang blended into a finished hair oil is a different exposure from neat essential oil, but if you are particularly cautious, check the ingredient list and patch test.

• Choose well-formulated products with transparent ingredient lists. Mylo's Onion Hair Oil combines onion seed oil with Amla, Bhringraj, Methi and Vitamins A and D3 in a published, ingredient-transparent 200 ml formulation.

• Do not stack with contraindicated agents. Avoid combining onion oil with finasteride-based products or retinoids.

• When in doubt, ask your dermatologist or paediatrician before starting any new product during breastfeeding.

Frequently Asked Questions

How does onion oil compare to minoxidil during breastfeeding? There is no clean ranking, because the two sit on very different evidence bases. Topical minoxidil is well studied, and the 2025 International Journal of Dermatology review classifies it as generally low-risk during lactation, while advising cautious use, particularly around premature infants (Needle et al., 2025). Onion oil has no dedicated breastfeeding studies at all, so it cannot be ranked against minoxidil on evidence. What can be said is that neither carries a clear high-risk flag, and onion oil has no hormonal-activity concern.

Can onion smell transfer through breast milk to my baby? Eating onion can flavour breast milk, but topical onion oil on the scalp is a separate and far smaller exposure. Dietary onion has been documented to change the flavour of breast milk. There are no published data showing that topical onion oil transfers detectable compounds into milk. Washing your hands and keeping the oil off the nipple area are sensible basic precautions (FDA Derma-Smoothe/FS Scalp Oil Label, 2024).

How often can I apply onion oil while breastfeeding? A conservative starting point is 2 to 3 times a week as a pre-wash treatment. The original 2002 Journal of Dermatology clinical protocol used twice-daily application for 6 weeks (Sharquie and Al-Obaidi, 2002). During breastfeeding, a lighter 2 to 3 times weekly cadence aligns with the FDA's shortest-duration principle while you see how your scalp and routine respond (FDA Derma-Smoothe/FS Scalp Oil Label, 2024).

Are added essential oils in onion hair products a breastfeeding concern? The concern applies to concentrated, undiluted essential oils, not to small amounts blended into a finished product. Some essential oils have hormone-disrupting potential or higher absorption when used neat, which is why the 2025 alopecia-in-lactation review flagged rosemary oil as having insufficient data (Needle et al., 2025). In a well-formulated hair oil, essential-oil components are present at low levels. Even so, choosing products with transparent ingredient lists and patch testing first is sensible.

Should I patch test even if I used onion oil before pregnancy? Yes. Postpartum hormonal shifts can change skin sensitivity, so a fresh patch test is worth doing. Skin reactivity and immune response can change after delivery. Standard postpartum dermatology guidance is to patch test on the inner forearm for 24 hours before resuming any topical product after birth.

Sources

1. Needle C.D., Brinks A.L., Kearney C.A., et al. Alopecia Treatments in Breastfeeding: Safety and Clinical Considerations. International Journal of Dermatology, 2025; 64(12), 2215 — https://onlinelibrary.wiley.com/doi/10.1111/ijd.17940

2. HCPLive. Safety Considerations Highlighted for Alopecia Treatments During Breastfeeding, coverage of Needle et al., 2025 — https://www.hcplive.com/view/safety-considerations-highlighted-for-alopecia-treatments-during-breastfeeding

3. Sharquie K.E., Al-Obaidi H.K. Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. Journal of Dermatology, 2002; 29(6), 343 — verifiable on PubMed

4. ConcePTION project. Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree. Frontiers in Pharmacology, 2025 — https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1602018/full

5. FDA Derma-Smoothe/FS Scalp Oil Prescribing Information Label, accessdata.fda.gov, 2024 — add the exact accessdata.fda.gov label URL before publishing

6. Johns Hopkins Medicine. Postpartum Hair Loss, 2025 — https://www.hopkinsmedicine.org/health/wellness-and-prevention/postpartum-hair-loss

7. Mylo. Onion Hair range, Onion Hair Oil, Mylo Care, 2026 — https://mylofamily.com/category/onion-hair-products-6158